Weiss Multi-Strategy Advisers’s Traws Pharma TRAW Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4	Closed	-$68K	–	665
2017 Q1	$68K	Hold	4	–	–	﹤0.01%	531
2016 Q4	$55K	Hold	4	–	–	﹤0.01%	398
2016 Q3	$64K	Sell	4 -1	-20%	-$20.4K	﹤0.01%	406
2016 Q2	$154K	Hold	5	–	–	0.01%	383
2016 Q1	$154K	Hold	5	–	–	0.01%	432
2015 Q4	$254K	Buy	5 +1	+25%	+$74.1K	0.02%	340
2015 Q3	$328K	Hold	4	–	–	0.01%	350
2015 Q2	$571K	Hold	4	–	–	0.02%	372
2015 Q1	$581K	Buy	4 +1	+33%	+$164K	0.03%	353
2014 Q4	$584K	Buy	3 +1	+50%	+$245K	0.02%	327
2014 Q3	$430K	Hold	2	–	–	0.01%	444
2014 Q2	$491K	Sell	2 -1	-33%	-$295K	0.01%	525
2014 Q1	$1.2M	Sell	3 -1	-25%	-$602K	0.02%	442
2013 Q4	$2.35M	Buy	4 +3	+300%	+$2.84M	0.05%	314
2013 Q3	$1.99M	Buy	+1	New	+$1.43M	0.04%	342

Other funds holding TRAW

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HFM

Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TRAW Position: Q2 2017 in Review

Weiss Multi-Strategy Advisers sold out of Traws Pharma (TRAW) in Q2 2017, closing a stake of 4 shares — an estimated $68K sold.

Weiss Multi-Strategy Advisers first reported a position in TRAW in Q3 2013 and held it in 15 quarters. The position peaked at $2.35M in Q4 2013. 9 funds tracked by Wall St. Rank hold TRAW as of Q2 2017.

Weiss Multi-Strategy Advisers reported no remaining Traws Pharma position as of Q2 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 4 Traws Pharma shares in Q2 2017, an estimated $68K.
Weiss Multi-Strategy Advisers first reported a position in Traws Pharma in Q3 2013 and held it in 15 quarters.
Weiss Multi-Strategy Advisers's Traws Pharma position peaked at $2.35M in Q4 2013.
9 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2017, filed 14 Aug 2017.